Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival Share Facebook Twitter LinkedIn Tumblr Pinterest Reddit Messenger Messenger WhatsApp Telegram Viber Line Share via Email